APOA1 and Alzheimer disease: Building on this “endophenotype” discovery approach we subsequently found transthyretin (TTR) and apolipoprotein A1 (ApoA1) to be associated with faster declining AD subjects and increased plasma apolipoprotein E (ApoE) levels related to increased Aβ burden in the brain [8], [9].